ICON Eyecare participates in several national clinical research trials in an effort to enrich and develop better treatment options for our patients for a variety of medical ophthalmic conditions and diseases including glaucoma, dry eye, and cataracts.
If you are interested in learning more or participating in any of our ongoing clinical research trials, please contact Chris Bosch, Clinical Research Coordinator at 970.205.9555 or Chris.Bosch@iconeyecare.com.
GLK-601’ by Glaukos Corp.: For individuals at least 2 years of age with persistent corneal epithelial defects
‘GLK-102’ by Glaukos Corp.: For adults with glaucoma OR ocular hypertension
‘Sapphire’ by Avisi Technologies Inc.: For adults 45+ with uncontrolled open-angle glaucoma
‘Spyglass’ by SpyGlass Pharma, Inc.: For adults 22+ with cataracts AND open-angle glaucoma
‘GLK-122’ by Glaukos corp.: For adults 18-29 years of age with keratoconus
‘GLK-411’ by Glaukos corp.: For adults 45+ with uncontrolled primary open-angle glaucoma
‘ViaLase’ by ViaLase, Inc.: For adults 40+ with open angle glaucoma
‘VELOS-4’ by HanAll Biopharma Co., Ltd.: For adults with dry eye disease
Pay Bill
Patient Portal
